Bio Techne Corp Stock Probability of Future Stock Price Finishing Over 74.17
| TECH Stock | USD 71.28 0.23 0.32% |
Bio |
Bio Techne Target Price Odds to finish over 74.17
The tendency of Bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 74.17 or more in 90 days |
| 71.28 | 90 days | 74.17 | about 40.25 |
Based on a normal probability distribution, the odds of Bio Techne to move over $ 74.17 or more in 90 days from now is about 40.25 (This Bio Techne Corp probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) . Probability of Bio Techne Corp price to stay between its current price of $ 71.28 and $ 74.17 at the end of the 90-day period is about 34.9 .
Given the investment horizon of 90 days Bio Techne has a beta of 0.93. This usually implies Bio Techne Corp market returns are responsive to returns on the market. As the market goes up or down, Bio Techne is expected to follow. Additionally Bio Techne Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Bio Techne Price Density |
| Price |
Predictive Modules for Bio Techne
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio Techne Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Techne Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bio Techne is not an exception. The market had few large corrections towards the Bio Techne's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bio Techne Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bio Techne within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 0.93 | |
σ | Overall volatility | 3.12 | |
Ir | Information ratio | -0.04 |
Bio Techne Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bio Techne for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bio Techne Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bio Techne Corp has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| On 22nd of November 2024 Bio Techne paid $ 0.08 per share dividend to its current shareholders | |
| Latest headline from businesswire.com: OverT Bio Receives 120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements |
Bio Techne Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bio Stock often depends not only on the future outlook of the current and potential Bio Techne's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Techne's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 160.8 M | |
| Cash And Short Term Investments | 152.9 M |
Bio Techne Technical Analysis
Bio Techne's future price can be derived by breaking down and analyzing its technical indicators over time. Bio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bio Techne Corp. In general, you should focus on analyzing Bio Stock price patterns and their correlations with different microeconomic environments and drivers.
Bio Techne Predictive Forecast Models
Bio Techne's time-series forecasting models is one of many Bio Techne's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bio Techne's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Bio Techne Corp
Checking the ongoing alerts about Bio Techne for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bio Techne Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bio Techne Corp has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| On 22nd of November 2024 Bio Techne paid $ 0.08 per share dividend to its current shareholders | |
| Latest headline from businesswire.com: OverT Bio Receives 120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements |
Check out Bio Techne Backtesting, Bio Techne Valuation, Bio Techne Correlation, Bio Techne Hype Analysis, Bio Techne Volatility, Bio Techne History as well as Bio Techne Performance. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.32) | Dividend Share 0.32 | Earnings Share 0.95 | Revenue Per Share 7.424 | Quarterly Revenue Growth 0.045 |
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.